For research use only. Not for therapeutic Use.
Flucytosine(Cat No.:A000838)is a fluorinated pyrimidine analog with potent antifungal activity, commonly used in research and clinical applications. It targets fungal cells by converting into 5-fluorouracil, disrupting RNA and DNA synthesis. Effective against Candida, Cryptococcus, and certain molds, Flucytosine is often combined with other antifungal agents, such as amphotericin B, to enhance efficacy and reduce resistance. Its unique mechanism and selective toxicity to fungal cells make it a valuable tool in antifungal drug development. Research focuses on optimizing dosing and managing resistance for improved therapeutic outcomes.
Catalog Number | A000838 |
CAS Number | 2022-85-7 |
Synonyms | 5-Fluorocytosine; Flucytosine; 2022-85-7; Ancotil; Ancobon; Flucytosin |
Molecular Formula | C4H4FN3O |
Purity | ≥95% |
Target | Antibiotic |
Solubility | >6.4mg/mL in DMSO |
Storage | -20°C |
IUPAC Name | 6-amino-5-fluoro-1H-pyrimidin-2-one |
InChI | InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) |
InChIKey | XRECTZIEBJDKEO-UHFFFAOYSA-N |
SMILES | C1=NC(=O)NC(=C1F)N |
Reference | 1: Fang XF, Li D, Tangadanchu VKR, Gopala L, Gao WW, Zhou CH. Novel potentially <br> 3: Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Population structure and molecular 4: Wani MY, Ahmad A, Kumar S, Sobral AJ. Flucytosine analogues obtained through 5: Husseini F, Delord JP, Fournel-Federico C, Guitton J, Erbs P, Homerin M, 6: Pais P, Pires C, Costa C, Okamoto M, Chibana H, Teixeira MC. Membrane 7: Berger AG, Restaino SM, White IM. Vertical-flow paper SERS system for 8: Tsuji G, Matsuda T, Shigyo A, Matsuda T, Furue M. Primary cutaneous 9: Costabile G, d/’Angelo I, d/’Emmanuele di Villa Bianca R, Mitidieri E, Pompili 10: Claustre J, Brion JP, Quétant S, Bedouch P, Pison C, Camara B. Favorable |